دورية أكاديمية
Anaemia, microcytosis and sirolimus-is iron the missing link?
العنوان: | Anaemia, microcytosis and sirolimus-is iron the missing link? |
---|---|
المؤلفون: | Sofroniadou, Sofia, Kassimatis, Theodoros, Goldsmith, David |
المصدر: | Sofroniadou , S , Kassimatis , T & Goldsmith , D 2010 , ' Anaemia, microcytosis and sirolimus-is iron the missing link? ' , Nephrology, Dialysis, Transplantation , vol. 25 , no. 5 , pp. 1667-1675 . https://doi.org/10.1093/ndt/gfp674Test |
سنة النشر: | 2010 |
المجموعة: | King's College, London: Research Portal |
مصطلحات موضوعية: | iron, microcytosis, post-transplantation anaemia, sirolimus, RENAL-TRANSPLANT RECIPIENTS, POSTTRANSPLANTATION ANEMIA, PRIMARY IMMUNOSUPPRESSION, ALLOGRAFT RECIPIENTS, ERYTHROPOIESIS, EXPERIENCE, EVEROLIMUS, DEFICIENCY, RAPAMYCIN, ADULT |
الوصف: | Background. Sirolimus (SRL) has been implicated in the causation of post-transplantation anaemia (PTA). It also induces profound red blood cell (RBC) microcytosis, which is poorly understood. Methods. We conducted a retrospective study of SRL-induced anaemia and microcytosis [mean corpuscular volume (MCV) <80 fl] with specific reference to iron homeostasis in 93 renal transplant patients treated with SRL for at least 3 months. Results. While mean haemoglobin (Hb) and use of erythropoiesis-stimulating agents increased on SRL, RBC MCV underwent a significant decline throughout the whole study period of 24 months (P <0.001) with the percentage of microcytosis rising from 2.2% at the start of SRL therapy to 40.7% after 24 months of therapy. An association between dMCV (MCV change on SRL) and SRL levels was shown at 3, 6, 12 and 24 months post-SRL (P = 0.015, P = 0.037, P = 0.002 and P = 0.001, respectively). Intravenous (IV) iron administration was an independent predictor of dMCV at 12 and 24 months on SRL (P = 0.031 and P = 0.048, respectively). All patients who, after starting SRL and seeing a fall in MCV, then went on to receive IV iron therapy, showed a marked increase in MCV; this did not happen to patients given oral iron therapy. Conclusions. SRL is associated with mild anaemia, but marked RBC microcytosis-these phenomena are correlated with SRL levels and the use of IV iron. Functional iron deficiency and impaired gastrointestinal absorption of iron seem likely explanations. |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
DOI: | 10.1093/ndt/gfp674 |
الإتاحة: | https://doi.org/10.1093/ndt/gfp674Test https://kclpure.kcl.ac.uk/portal/en/publications/8985dc2a-2a81-4ab8-b30c-610d7b2b4910Test |
حقوق: | info:eu-repo/semantics/openAccess |
رقم الانضمام: | edsbas.342CBD75 |
قاعدة البيانات: | BASE |
ResultId |
1 |
---|---|
Header |
edsbas BASE edsbas.342CBD75 841 3 Academic Journal academicJournal 841.324340820313 |
PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsbas&AN=edsbas.342CBD75&custid=s6537998&authtype=sso |
FullText |
Array
(
[Availability] => 0
)
Array ( [0] => Array ( [Url] => https://doi.org/10.1093/ndt/gfp674# [Name] => EDS - BASE [Category] => fullText [Text] => View record in BASE [MouseOverText] => View record in BASE ) ) |
Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => Anaemia, microcytosis and sirolimus-is iron the missing link?
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Sofroniadou%2C+Sofia%22">Sofroniadou, Sofia</searchLink><br /><searchLink fieldCode="AR" term="%22Kassimatis%2C+Theodoros%22">Kassimatis, Theodoros</searchLink><br /><searchLink fieldCode="AR" term="%22Goldsmith%2C+David%22">Goldsmith, David</searchLink> ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => Sofroniadou , S , Kassimatis , T & Goldsmith , D 2010 , ' Anaemia, microcytosis and sirolimus-is iron the missing link? ' , Nephrology, Dialysis, Transplantation , vol. 25 , no. 5 , pp. 1667-1675 . https://doi.org/10.1093/ndt/gfp674 ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2010 ) Array ( [Name] => Subset [Label] => Collection [Group] => HoldingsInfo [Data] => King's College, London: Research Portal ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22iron%22">iron</searchLink><br /><searchLink fieldCode="DE" term="%22microcytosis%22">microcytosis</searchLink><br /><searchLink fieldCode="DE" term="%22post-transplantation+anaemia%22">post-transplantation anaemia</searchLink><br /><searchLink fieldCode="DE" term="%22sirolimus%22">sirolimus</searchLink><br /><searchLink fieldCode="DE" term="%22RENAL-TRANSPLANT+RECIPIENTS%22">RENAL-TRANSPLANT RECIPIENTS</searchLink><br /><searchLink fieldCode="DE" term="%22POSTTRANSPLANTATION+ANEMIA%22">POSTTRANSPLANTATION ANEMIA</searchLink><br /><searchLink fieldCode="DE" term="%22PRIMARY+IMMUNOSUPPRESSION%22">PRIMARY IMMUNOSUPPRESSION</searchLink><br /><searchLink fieldCode="DE" term="%22ALLOGRAFT+RECIPIENTS%22">ALLOGRAFT RECIPIENTS</searchLink><br /><searchLink fieldCode="DE" term="%22ERYTHROPOIESIS%22">ERYTHROPOIESIS</searchLink><br /><searchLink fieldCode="DE" term="%22EXPERIENCE%22">EXPERIENCE</searchLink><br /><searchLink fieldCode="DE" term="%22EVEROLIMUS%22">EVEROLIMUS</searchLink><br /><searchLink fieldCode="DE" term="%22DEFICIENCY%22">DEFICIENCY</searchLink><br /><searchLink fieldCode="DE" term="%22RAPAMYCIN%22">RAPAMYCIN</searchLink><br /><searchLink fieldCode="DE" term="%22ADULT%22">ADULT</searchLink> ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => Background. Sirolimus (SRL) has been implicated in the causation of post-transplantation anaemia (PTA). It also induces profound red blood cell (RBC) microcytosis, which is poorly understood. Methods. We conducted a retrospective study of SRL-induced anaemia and microcytosis [mean corpuscular volume (MCV) <80 fl] with specific reference to iron homeostasis in 93 renal transplant patients treated with SRL for at least 3 months. Results. While mean haemoglobin (Hb) and use of erythropoiesis-stimulating agents increased on SRL, RBC MCV underwent a significant decline throughout the whole study period of 24 months (P <0.001) with the percentage of microcytosis rising from 2.2% at the start of SRL therapy to 40.7% after 24 months of therapy. An association between dMCV (MCV change on SRL) and SRL levels was shown at 3, 6, 12 and 24 months post-SRL (P = 0.015, P = 0.037, P = 0.002 and P = 0.001, respectively). Intravenous (IV) iron administration was an independent predictor of dMCV at 12 and 24 months on SRL (P = 0.031 and P = 0.048, respectively). All patients who, after starting SRL and seeing a fall in MCV, then went on to receive IV iron therapy, showed a marked increase in MCV; this did not happen to patients given oral iron therapy. Conclusions. SRL is associated with mild anaemia, but marked RBC microcytosis-these phenomena are correlated with SRL levels and the use of IV iron. Functional iron deficiency and impaired gastrointestinal absorption of iron seem likely explanations. ) Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => article in journal/newspaper ) Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English ) Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1093/ndt/gfp674 ) Array ( [Name] => URL [Label] => Availability [Group] => URL [Data] => https://doi.org/10.1093/ndt/gfp674<br />https://kclpure.kcl.ac.uk/portal/en/publications/8985dc2a-2a81-4ab8-b30c-610d7b2b4910 ) Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => info:eu-repo/semantics/openAccess ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsbas.342CBD75 ) |
RecordInfo |
Array
(
[BibEntity] => Array
(
[Identifiers] => Array
(
[0] => Array
(
[Type] => doi
[Value] => 10.1093/ndt/gfp674
)
)
[Languages] => Array
(
[0] => Array
(
[Text] => English
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => iron
[Type] => general
)
[1] => Array
(
[SubjectFull] => microcytosis
[Type] => general
)
[2] => Array
(
[SubjectFull] => post-transplantation anaemia
[Type] => general
)
[3] => Array
(
[SubjectFull] => sirolimus
[Type] => general
)
[4] => Array
(
[SubjectFull] => RENAL-TRANSPLANT RECIPIENTS
[Type] => general
)
[5] => Array
(
[SubjectFull] => POSTTRANSPLANTATION ANEMIA
[Type] => general
)
[6] => Array
(
[SubjectFull] => PRIMARY IMMUNOSUPPRESSION
[Type] => general
)
[7] => Array
(
[SubjectFull] => ALLOGRAFT RECIPIENTS
[Type] => general
)
[8] => Array
(
[SubjectFull] => ERYTHROPOIESIS
[Type] => general
)
[9] => Array
(
[SubjectFull] => EXPERIENCE
[Type] => general
)
[10] => Array
(
[SubjectFull] => EVEROLIMUS
[Type] => general
)
[11] => Array
(
[SubjectFull] => DEFICIENCY
[Type] => general
)
[12] => Array
(
[SubjectFull] => RAPAMYCIN
[Type] => general
)
[13] => Array
(
[SubjectFull] => ADULT
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Anaemia, microcytosis and sirolimus-is iron the missing link?
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Sofroniadou, Sofia
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Kassimatis, Theodoros
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Goldsmith, David
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 01
[M] => 01
[Type] => published
[Y] => 2010
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-locals
[Value] => edsbas
)
[1] => Array
(
[Type] => issn-locals
[Value] => edsbas.oa
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => $2
[Type] => main
)
)
)
)
)
)
)
|
IllustrationInfo |